US Patent 8,209,129 has issued on single copy DNA probes which include divergent repetitive sequences, thus significantly extending the portions of the genome that can be used for such probes [...]
Cytognomix’s new software product, the Shannon pipeline for human splicing mutation analysis of NGS sequencing data was presented at the BioIT World Conference and Expo (Apr 24-26, 2012), Boston. Dr. [...]
Cytognomix receives US Patent 7,734,424 entitled “AB INITIO GENERATION OF SINGLE COPY GENOMIC PROBES.”
Ontario Centre of Excellence for Commercialization of Research assists Cytognomix in building capacity through its Embedded Executive Program.
Canadian Institute for Photonic Innovations awards grant to the University of Western Ontario and Cytognomix through their Technology Exploitation and Networking Program.
MaRS Ventures Inc. (Toronto) accepts Cytognomix as a client of the Business Mentorship Entrepreneurship Program.
Cytognomix becomes a client of the NRC-IRAP program and receives an initial investment to create jobs in Ontario.
Cytognomix receives award for Innovation and Receives Investment. Cytognomix recognized by the Stiller Centre for Technology. Commercialization and OGI for its development of DNA probes that can detect genetic mutations [...]
Through its Pre-commercialization Business Development Fund (PBDF) program, the Ontario Genomics Institute (OGI) has invested in Cytognomix, to enable development of novel cytogenetic DNA probes that pinpoint genomic anomalies at [...]
The Government of Canada awards the Canada Research Chair in Genome Bioinformatics (Tier I) to Peter Rogan. Read full story Profile: Canada Research Chairs website October 1, 2010. Shane Climie [...]